Table 2

Antibody titers of predominant responses in selected bleeds of XMRV-infected macaques and goat polyclonal antibodies to MuLV.

Sample

Days post XMRV Infection

Antibody Titers by ARCHITECT CMIAs


1st

Infection

2nd

Infection

Immuni-

zation

Anti-gp70

Anti-p15E

Anti-p30


RIl-10

42

800

40

2


134

3,200

160

10


167

9

128,000

12,800

640


210

52

32,000

800

80


291

133

16

16,000

8,000

4,000


RYh-10

42

1,600

80

10


134

1,600

80

10


167

9

32,000

6,400

640


210

52

8,000

400

80


291

133

16

4,000

4,000

2,000


RLq-10

42

800

80

1


134

800

160

1


Anti-MuLV pAb

16,000

32,000

64,000


Anti-Env pAb

10,000


Anti-His Mab

0.039 nM

1.18 nM


Anti-p30 Mab

0.56 nM


Antibody titers were determined by the three direct gp70, p15E and p30 CMIAs on samples serially diluted with negative normal human plasma, and expressed as the reciprocal of the bleed dilution giving a reactive result. For comparison, detection limits of the anti-His and anti-p30 monoclonal antibodies were also listed.

Qiu et al. Retrovirology 2010 7:68   doi:10.1186/1742-4690-7-68

Open Data